AMBU., LTD. - Medical Device Manufacturer in Indonesia
AMBU., LTD. from China is a medical device manufacturer with 6 registered products in the Indonesia BPOM database through Pure Global AI's free platform. The company produces 6 unique product types across 1 product class.
This page provides comprehensive manufacturer intelligence including complete product portfolio, risk class distribution, and product class analysis. Pure Global AI offers free access to 67,600+ Indonesia medical device registrations, helping global MedTech companies identify manufacturers, analyze portfolios, and discover partnership opportunities efficiently.
Free Manufacturer Profile
Powered by Pure Global AI
6 Products
1 Classes
๐ฎ๐ฉ
AMBU., LTD.
China
6
Total Products
6
Product Names
1
Product Classes
1
Risk Classes
Risk Classification Breakdown
Distribution of products across risk classes
Kelas Resiko : B
6 products100.0%
Product Class Portfolio
Products organized by product class
Kelas : 2
6 Products
AMBU Mark IV Resuscitator
Kelas Resiko : B
Mar 13, 2024
AMBU Oval Plus Silicone Resuscitator
Kelas Resiko : B
Mar 8, 2024
AMBU SPUR II Resuscitator
Kelas Resiko : B
Mar 6, 2024
AMBU Mark lV Resuscitator
Kelas Resiko : B
Feb 27, 2024
AMBU Aura-I Single Use Laryngeal Mask
Kelas Resiko : B
Jan 11, 2024
... and 1 more products in this class
Recent Registrations (6 most recent)
Most recently registered products with BPOM
AMBU Mark IV Resuscitator
Class:
Kelas : 2
Risk Class:
Kelas Resiko : B
Registration Date:
Mar 13, 2024
AMBU Oval Plus Silicone Resuscitator
Class:
Kelas : 2
Risk Class:
Kelas Resiko : B
Registration Date:
Mar 8, 2024
AMBU SPUR II Resuscitator
Class:
Kelas : 2
Risk Class:
Kelas Resiko : B
Registration Date:
Mar 6, 2024
AMBU Mark lV Resuscitator
Class:
Kelas : 2
Risk Class:
Kelas Resiko : B
Registration Date:
Feb 27, 2024
AMBU Aura-I Single Use Laryngeal Mask
Class:
Kelas : 2
Risk Class:
Kelas Resiko : B
Registration Date:
Jan 11, 2024
AMBU AuraGain Single Use Laryngeal Mask
Class:
Kelas : 2
Risk Class:
Kelas Resiko : B
Registration Date:
Jan 11, 2024

